Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) [Phase 1]
Phase 1 clinical trial evaluating safety and toxicity of SBRT followed by intratumoral PCX12 immunotherapy for locally advanced pancreatic a…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating photoradiation with verteporfin to enhance the immunologic activity of pembrolizumab in unresectable locally advanc…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma [Phase 1]
An ongoing Phase 1 trial evaluating OMTX705 in combination with gemcitabine/nab-paclitaxel and tislelizumab for advanced/metastatic pancreat…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Recruitment is ongoing for a clinical trial studying the relationship between genomic polymorphisms and cancer cachexia in patients with pan…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Seven Trial: Exploiting the Unfolded Protein Response [Phase 1]
A Phase 1 clinical trial called The Seven Trial is exploring exploitation of the unfolded protein response in metastatic pancreatic cancer, …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer [NA]
This clinical trial update notes that a study combining stereotactic body radiation with tumor treating fields is currently recruiting for l…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Identify microRNAs in Cachexia in Pancreatic Carcinoma
A clinical trial is evaluating microRNAs linked to cachexia in patients with resectable pancreatic adenocarcinoma; the study is currently re…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Adenovirus (RGDCRAdCOX2F) [Phase 1]
Phase 1 clinical trial evaluating an adenovirus therapy, RGDCRAdCOX2F, for pancreatic adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating NH002-mediated sonoporation with chemotherapy for advanced pancreatic cancer is currently not yet recrui…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy [Phase 2]
A Phase 2 clinical trial is evaluating irreversible electroporation (IRE) combined with a PD-1/CTLA-4 dual-function antibody for locally adv…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy [Phase 2]
A Phase 2 clinical trial is evaluating cryoablation combined with a PD-1/CTLA-4 dual-function antibody for locally advanced pancreatic adeno…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma [Phase 1, Phase 2]
A Phase I/IIa clinical trial of RR001 for locally advanced pancreatic adenocarcinoma is currently recruiting after chemotherapy cycles.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma [Phase 2]
This update describes an ongoing Phase II clinical trial at Yale evaluating a modified FOLFIRINOX chemotherapy regimen together with stereot…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating BMS-986340 in combination with nivolumab, gemcitabine, and nab-paclitaxel for metastatic and recurrent pan…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating Ivaltinostat with Capecitabine (or Capecitabine alone) for metastatic pancreatic adenocarcinoma;…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pancreatic Cancer Detection Consortium
This Clinical Trial Update describes the Pancreatic Cancer Detection Consortium sponsored by City of Hope Medical Center, currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy [NA]
This clinical trial evaluates Superb Microvascular Imaging and two-dimensional EUS-guided shear wave elastography to differentiate pancreati…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer [NA]
A clinical trial entry describing the Alpha DaRT diffusing alpha-emitters radiation therapy device for locally advanced or unresectable panc…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer [NA]
This update describes a feasibility and safety study of intratumoral diffusing alpha radiation emitters for advanced pancreatic cancer. The …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating sequential GEMBRAX followed by FOLFIRINOX and then stereotactic MRI-guided radiotherapy for locally a…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer [NA]
Clinical trial update indicates Alpha Tau Medical's alpha radiation emitter device is being studied for advanced pancreatic cancer and is cu…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 1]
This is a Phase 1 clinical trial update for a combination of calaspargase pegol-mnkl and cobimetinib in locally advanced or metastatic pancr…